- Report
- May 2024
- 133 Pages
Global
From €3619EUR$3,999USD£3,091GBP
- Report
- April 2023
- 117 Pages
Global
From €4298EUR$4,750USD£3,671GBP
- Report
- April 2023
- 129 Pages
Global
From €4298EUR$4,750USD£3,671GBP
- Report
- June 2026
- 117 Pages
Mexico
From €3619EUR$3,999USD£3,091GBP
- Report
- May 2024
- 132 Pages
Global
From €3619EUR$3,999USD£3,091GBP
- Report
- May 2024
- 133 Pages
Global
From €3619EUR$3,999USD£3,091GBP
- Report
- May 2024
- 138 Pages
Global
From €3619EUR$3,999USD£3,091GBP
- Report
- January 2025
- 144 Pages
Global
From €3574EUR$3,950USD£3,053GBP
- Report
- April 2023
- 78 Pages
Global
From €3163EUR$3,495USD£2,701GBP
- Drug Pipelines
- June 2022
- 101 Pages
Global
From €13569EUR$14,995USD£11,590GBP
- Report
- July 2024
Global
From €4389EUR$4,850USD£3,749GBP
- Report
- January 2026
- 150 Pages
Japan
From €4389EUR$4,850USD£3,749GBP
- Report
- January 2026
- 150 Pages
India
From €4389EUR$4,850USD£3,749GBP
- Report
- October 2025
- 150 Pages
Germany
From €4389EUR$4,850USD£3,749GBP
- Report
- September 2025
- 150 Pages
China
From €4389EUR$4,850USD£3,749GBP
- Report
- September 2025
- 150 Pages
Canada
From €4389EUR$4,850USD£3,749GBP
- Report
- April 2025
- 150 Pages
Global
From €4389EUR$4,850USD£3,749GBP
- Report
- March 2025
- 150 Pages
Global
From €4389EUR$4,850USD£3,749GBP
- Report
- June 2025
- 76 Pages
Global
From €3500EUR$4,143USD£3,094GBP
- Report
- May 2025
- 90 Pages
Global
From €3500EUR$4,143USD£3,094GBP

Calcium Channel Blockers (CCBs) are a class of drugs used to treat cardiovascular diseases such as hypertension, angina, and arrhythmias. They work by blocking the entry of calcium ions into the cells of the heart and blood vessels, thus reducing the force of contraction of the heart and dilating the blood vessels. This reduces the workload on the heart and lowers blood pressure. CCBs are also used to treat other conditions such as migraine headaches and Raynaud's phenomenon.
CCBs are generally well tolerated and have few side effects. Common side effects include dizziness, headache, and swelling of the ankles. They may also interact with other medications, so it is important to discuss all medications with a doctor before taking CCBs.
The CCB market is a major component of the cardiovascular drug market. It is a highly competitive market, with many companies offering a variety of CCBs. Some of the major companies in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more